<html><head><link rel="stylesheet" type="text/css" href="css/style.css"></head><body><div id="main"><h1>Scignal</h1></div> <div class="container"><div class="row"><div class="search"><h2>All Results for : "cystic fibrosis" and "editing" OR "therapy" OR "therapies"</a></h2></div><table><tr><td class="head"><h3>BioRxiv</h3></td><td class="head"><h3>PubMed</h3></td></tr><tr><div class="row"><td></td><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Functional Carbon Quantum Dots as Medical Countermeasures to Human Coronavirus.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/31633330">Link</a></p><p><b>Date:</b> 10/21/2019</p><p><b>Authors:</b> Aleksandra ≈Åoczechin ...  Sabine Szunerits</p><p><b>Journal:</b> ACS Appl Mater Interfaces</p><p><b>IF (7 or above):</b> 8.33</p><p><b>Relevance Score:</b> 0.29</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Therapeutic options for the highly pathogenic human coronavirus (HCoV) infections are urgently needed.  Anticoronavirus therapy is however challenging, as coronaviruses are biologically diverse and rapidly mutating.</p></div></td></div></tr><tr><div class="row"><td></td><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/31618560">Link</a></p><p><b>Date:</b> 10/16/2019</p><p><b>Authors:</b> Sue A Brown ...  None None</p><p><b>Journal:</b> N. Engl. J. Med.</p><p><b>IF (7 or above):</b> 37.91</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> BACKGROUND: Closed-loop systems that automate insulin delivery may improve glycemic outcomes in patients with type 1 diabetes. 
METHODS: In this 6-month randomized, multicenter trial, patients with type 1 diabetes were assigned in a 2:1 ratio to receive treatment with a closed-loop system (closed-lo ....</p></div></td></div></tr></table></div><hr></div></body></html>